ASHU TYAGI
CIK 1752467 · last filed 2025-09-18
ASHU TYAGI is a corporate insider who has filed 9 SEC Form 4 insider transactions across 1 company since 2018. Across all open-market trades the lifetime net is +$6.9M, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
9
$6.88M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Director | 1,423,645 | $8.61 | $12.26M | $6.88M | 8 | 2025-07-02 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-18 | — | Mixed | −30,905 | -$50.1K | |
| 2025-07-02 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | +25,080 | $0 | EDGAR |
| 2024-06-13 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | +3,495 | $0 | EDGAR |
| 2023-06-09 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | +2,330 | $0 | EDGAR |
| 2022-07-19 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-14 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-24 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-14 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-09-26 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Buy (P) | +430,174 | $6.88M | EDGAR |